Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Actin gamma 1 pseudogene 18 (ACTG1P18) is a human pseudogene related to the actin gamma 1 gene (ACTG1). Pseudogenes are segments of DNA that resemble functional genes but typically do not produce a functional protein due to mutations, lack of regulatory elements, or other disruptions. ACTG1P18 does not encode actin gamma 1 or any other known protein, nor does it appear to have any direct biological, disease, or drug-relevant function. There is no available evidence that ACTG1P18 has regulatory or pathological roles, though some pseudogenes can influence gene regulation in rare cases. This entry is correctly classified as a pseudogene and not as a protein-coding therapeutic target.
None relevant for drug targeting.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Actin gamma 1 pseudogene 18 (ACTG1P18).